Pre-Clinical Preparation for a Study of CD200 Receptor Ligand and Allogeneic Tumor Lysate VaccineImmunotherapy

Project: Research project

Description

Pre-Clinical Preparation for a Study of CD200 Receptor Ligand and Allogeneic Tumor Lysate Vaccine Immunotherapy
StatusFinished
Effective start/end date8/1/187/31/19

Funding

  • OX2 THERAPEUTICS, INC.

Fingerprint

Tumors
Vaccines
Ligands